Drug interactions
Paclitaxel protein bound + Sorafenib
Severity: Moderate
Paclitaxel protein bound and Sorafenib: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Sorafenib can inhibit CYP2C8, which is a main route of paclitaxel metabolism, so paclitaxel exposure may rise. This could increase myelosuppression and neuropathy, although the clinical impact is not well established.
What this interaction means in plain words
Paclitaxel protein bound and Sorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Inhibition of CYP2C8-mediated paclitaxel metabolism by sorafenib.
What to do
Monitor blood counts and neuropathy symptoms closely. Reduce the paclitaxel dose if toxicity occurs.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Paclitaxel protein bound and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Sorafenib
Frequently asked questions
Can I take Paclitaxel protein bound with Sorafenib?
MediHelp rates the interaction as moderate. Paclitaxel protein bound and Sorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sorafenib can inhibit CYP2C8, which is a main route of paclitaxel metabolism, so paclitaxel exposure may rise. This could increase myelosuppression and neuropathy, although the clinical impact is not well established.
How serious is the interaction between Paclitaxel protein bound and Sorafenib?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and neuropathy symptoms closely. Reduce the paclitaxel dose if toxicity occurs.
What other medicines interact with Sorafenib?
MediHelp also lists interactions of Sorafenib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sorafenib page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
